Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Andrew Clerman
Institutions:
United States Food and Drug Administration,
Center for Drug Evaluation and Research
Observed institutions:
University of Maryland, Baltimore,
United States Food and Drug Administration,
Center for Drug Evaluation and Research,
University of Maryland School of Medicine
ORCID:
0009-0008-0230-3677
Observed ORCID:
0009-0008-0230-3677
OpenAlex ID:
A5071981052
Stimulation of PGE2 receptors EP2 and EP4 protects cultured neurons against oxidative stress and cell death following β‐amyloid exposure
2005
·
Valentina Echeverria
, Andrew Clerman
, et al.
·
European Journal of Neuroscience
·
129
Transcriptomic evidence of immune activation in macroscopically normal-appearing and scarred lung tissues in idiopathic pulmonary fibrosis
2018
·
Irina G. Luzina
, Mariah V. Salcedo
, et al.
·
Cellular Immunology
·
69
PDF
The full-length interleukin-33 (FLIL33)–importin-5 interaction does not regulate nuclear localization of FLIL33 but controls its intracellular degradation
2017
·
Andrew Clerman
, Zahid Noor
, et al.
·
Journal of Biological Chemistry
·
25
Identification of the IL-33 protein segment that controls subcellular localization, extracellular secretion, and functional maturation
2019
·
Irina G. Luzina
, Andrew Clerman
, et al.
·
Cytokine
·
17
PDF
A Descriptive Cohort Study of Drug Utilization Patterns Among Patients Hospitalized With Coronavirus Disease 2019 in the United States, January 2021–February 2022
2023
·
Sarah E Vititoe
, Priya Govil
, et al.
·
Open Forum Infectious Diseases
·
2
PDF
Proceedings of the 2024 FDA-CRCG Workshop: Scientific and Regulatory Considerations for Assessment of Immunogenicity Risk for Generic Peptide and Oligonucleotide Drug Products
2026
·
Jennifer K. Lee
, Ha-Na Lee
, et al.
·
The AAPS Journal
·
1
PDF
Comparative effectiveness and safety of generic vs. brand-name enoxaparin
2026
·
Shirley Wang Ph.D.
, William Feldman
, et al.
·
Open Science Framework
Comparative Use Human Factors Study of a Manual vs. A Partially Automated Pen Injector for GLP ‐1 Receptor Agonist Delivery
2026
·
Karthika Natarajan
, Andrew Clerman
, et al.
·
Clinical Pharmacology & Therapeutics
PDF
Comparative Effectiveness and Safety of Generic Versus Brand-Name Fluticasone–Salmeterol to Treat Chronic Obstructive Pulmonary Disease
2024
·
Andrew Clerman
, Markham Luke
·
Annals of Internal Medicine
Show more works
View as search
Works count:
9
Citation count:
243
H-index:
4
I10-index:
4
Year
Topic
Type